Pfizer Says Vaccine Trial Shows "Robust" Response In Kids 5 To 11Pfizer Says Vaccine Trial Shows "Robust" Response In Kids 5 To 11In weeks the FDA could approve emergency use authorization for Pfizer's 2-dose regimen. This comes after excellent trial data results for kids.Gina CookGina Cook
